US Patent 10973780 Ketamine formulation for subcutaneous injection
Patent 10973780 was granted and assigned to Bexson Biomedical on April, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10973780 Ketamine formulation for subcutaneous injection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
